Cell surface overexpression of galectin-3 and the presence of its ligand 90k in the blood plasma as determinants in colon neoplastic lesions

Glycobiology

Volumn 14, Issue 9, 2004, Pages 783-792

  Greco, Claudia ^a   Vona, Rosa ^a,b   Cosimelli, Maurizio ^c   Matarrese, Paola ^b   Straface, Elisabetta ^b   Scordati, Patrizia ^a   Giannarelli, Diana ^d   Casale, Vincenzo ^e   Assisi, Daniela ^e   Mottolese, Marcela ^a   Moles, Anna ^f   Malorni, Walter ^a,b  

^a Polo Oncologico Regina Elena   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c Surgical Department   (Italy)

^d Service of Statistics   (Italy)

^e Digestive Endoscopy Unit   (Italy)

^f CNR   (Italy)

Author keywords

Adenoma; Carcinoma; CD44v6; Colon; Galectin 3; K ras

Indexed keywords

BETA GALACTOSIDASE; BINDING PROTEIN; CD44V6 ANTIGEN; GALECTIN 3; K RAS PROTEIN; LIGAND;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL ADHESION; CELL SURFACE; CELL SURVIVAL; COLON ADENOCARCINOMA; COLON ADENOMA; COLON MUCOSA; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; EXTRACELLULAR MATRIX; FEMALE; FLOW CYTOMETRY; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FAMILY; THYROID TUMOR;

ADENOCARCINOMA; ADENOMA; BASE SEQUENCE; COLONIC NEOPLASMS; DNA PRIMERS; FLOW CYTOMETRY; GALECTIN 3; GENES, RAS; HUMANS; IMMUNOHISTOCHEMISTRY; LIGANDS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 4444371145     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: 10.1093/glycob/cwh092     Document Type: Article

References (48)

1. Abbasi, A.M., Chester, K.A., Talbot, I.C., Macpherson, A.S., Boxer, G., Forbes, A., Malcolm, A.D., and Begent, R.H. (1993) CD44 is associated with proliferation in normal and neoplastic human colorectal epithelial cells. Eur. J. Cancer, 29, 1995-2002.
2. Bartolazzi, A., Gasbarri, A., Papotti, M., Bussolati, G., Lucante, T., Khan, A., Inohara, H., Marandino, F., Orlandi, F., Nardi, F., and others. (2001) Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet, 26, 1644-1650.
3. Bresalier, R.S., Mazurek, N., Sternberg, L.R., Byrd, J.C., Yunker, C.K., Nangia-Makker, P., and Raz, A. (1998) Metastasis of human colon cancer is altered by modifying expression of the beta-galactoside-binding protein galectin 3. Gastroenterology, 115, 287-296.
4. Capella, G., Cronauer-Mitra, S., Pienado, M.A., and Perucho, M. (1991) Frequency and spectrum of mutations at codons 12 and 13 of the c-K-ras gene in human tumors. Environ. Health Perspect., 93, 125-131.
5. Cerra, R., Zarbo, R.J., and Crissman, J.D. (1990) Dissociation of cells from solid tumors. Meth. Cell. Biol., 33, 1-12.
6. Chritofori, G. (2003) Changing neighbours, changing behaviour: cell adhesion molecule-mediated signalling during tumour progression. EMBO J., 15, 2318-2323.
7. Danguy, A., Camby, I., and Kiss, R. (2002) Galectins and cancer. Biochim. Biophys. Acta, 1572, 285-293.
8. Finkelstein, S.D., Sayegh, R., Christensen, S., and Swalsky, P.A. (1993) Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K-ras-2 mutation type. Cancer, 71, 3827-3838.
9. Frisch, S.M., and Screaton, R.A. (2001) Anoikis mechanisms. Curr. Opin. Cell Biol., 13, 555-562.
10. Fukumori, T., Takenaka, Y., Yoshii, T., Kim, H.R., Hogan, V., Inohara, H., Kagawa, S., and Raz, A. (2003) CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis. Cancer Res., 63, 8302-8311.
11. Gasbarri, A., Martegani, M.P., Del Prete, F., Lucante, T., Natali, P.G., and Bartolazzi, A. (1999) Galectin-3 and CD44 v6 isofroms in the preoperative evaluation of thyroid nodules. J. Clin. Oncol., 17, 3494-3502.
12. Gorelik, E., Galili, U., and Raz, A. (2001) On the role of cell surface carbohydrates and their binding proteins (lectins) in tumor metastasis. Cancer Metast. Rev., 20, 245-277.
13. Grossmann, J. (2002) Molecular mechanisms of "detachment-induced apoptosis - anoikis." Apoptosis, 7, 247-260.
14. Guerrero, S., Casanova, I., Farre, I., Mazo, A., Capella, G., and Mangues, R. (2000) K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression. Cancer Res., 60, 6750-6756.
15. Gunthert, U., Hofmann, M., Rudy, W., Reber, S., Zoller, M., Haussmann, I., Matzku, S., Wenzel, A., Ponta, H., and Herrlich, P. (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell, 65, 13-24.
16. Herrlich, P., Pals, S., and Ponta, H. (1995) CD44 in colon cancer. Eur. J. Cancer, 31, 1110-1112.
17. Hittelet, A., Legendre, H., Nagy, N., Bronckart, Y., Pector, J.C., Salmon, I., Yeaton, P., Gabius, H.J., Kiss, R., and Camby, I. (2003) Upregulation of galectins-1 and -3 in human colon cancer and their role in regulating cell migration. Int. J. Cancer, 20, 370-379.
18. Inohara, H., Akahani, S., Koths, K., and Raz, A. (1996) Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion. Cancer Res., 56, 4530-4534.
19. Jothy, S. (2003) CD44 and its partners in metastasis. Clin. Exp. Metast., 20, 195-201.
20. Kahn, S.M., Jiang, W., Culbertson, T.A., Weinstein, I.B., Williams, G.M., Tomita, N., and Ronai, Z. (1991) Rapid and sensitive nonradioactive detection of mutant K-ras genes via "enriched" PCR amplification. Oncogene, 6, 1079-1083.
21. Kim, H., Yang, X.L., Rosada, C., Hamilton, S.H., and August, J.T. (1994) CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation. Arch. Biochem. Biophys., 310, 504-507.
22. Kim, H.R., Lin, H.M., Biliran, H., and Raz, A. (1999) Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells. Cancer Res., 59, 4148-4154.
23. Lahm, H., Andre, S., Hoeflich, A., Fischer, J.R., Sordat, B., Kaltner, H., Wolf, E., and Gabius, H.J. (2001) Comprehensive galectin fingerprinting in a panel 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures. J. Cancer Res. Clin. Oncol., 127, 375-386.
24. Liu, F.T., Patterson, R.J., and Wang, J.L. (2002) Intracellular funcion of galectins. Biochim. Biophis. Acta, 1572, 263-273.
25. Marchetti, A., Tinari, N., Buttitta, F., Chella, A., Angeletti, C.A., Sacco, R., Mucilli, F., Ullrich, A., and Iacobelli, S. (2002) Expression of 90K (Mac-2 BP) correlates with distant metastasis and predicts survival in stage I non-small cell lung cancer patients. Cancer Res., 62, 2535-2539.
26. Matarrese, P., Fusco, O., Tinari, N., Natoli, C., Liu, F.T., Semeraro, M.L., Malorni, W., and Iacobelli, S. (2000) Galectin-3 overexpression protects from apoptosis by improving cell adhesion properties. Int. J. Cancer, 85, 545-554.
27. Mottolese, M., Buglioni, S., Bracalenti, C., Cardarelli, M.A., Ciabocco, L., Giannarelli, D., Botti, C., Natali, P.G., Concetti, A., and Venanzi, F.M. (2000) Prognostic relevance of altered Fas (CD95)-system in human breast cancer. Int. J. Cancer, 89, 127-132.
28. Nagy, N., Legendre, H., Engels, O., Andre, S., Kaltner, H., Wasano, K., Zick, Y., Pector, J.C., Decaestecker, C., Gabius, H.J., and others. (2003) Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting. Cancer, 97, 1849-1858.
29. Nakamura, M., Inufusa, H., Adachi, T., Aga, M., Kurimoto, M., Nakatani, Y., Wakano, T., Nakajima, A., Hida, J.I., Miyake, M., and others. (1999) Involvement of galectin-3 expression in colorectal cancer progression and metastasis. Int. J. Oncol., 15, 143-148.
30. Nangia-Makker, P., Conklin, J., Hogan, V., and Raz, A. (2002) Carbohydrate-binding proteins in cancer, and their ligands as therapeutic agents. Trends Mol. Med., 8, 187-192.
31. Natoli, C., Iacobelli, S., and Kohn, L. (1996) The immune stimulatory protein 90K increases major histocompatibility complex class I expression in a human breast cancer cell line. Biochem. Biophys. Res. Commun., 225, 617-620.
32. Nikiforova, M.N., Lynch, R.A. Biddinger, P.W., Alexander, E.K., Dorn, G.W. II, Tallini, G., Kroll, T.G., and Nikiforov, Y.E. (2003) RAS point mutations and PAX8-PARP gamma rearrangement in tyroid tumors: evidence for distinct molecular pathways in tyroid follicular carcinoma. J. Clin. Endocrinol. Metab., 88, 2318-2326.
33. Ohene-Abuakwa, Y., and Pignatelli, M. (2000) Adhesion molecules in cancer biology. Adv. Exp. Med. Biol., 465, 115-126.
34. Okamoto, I., Tsuikj, H., Kenyon, L.C., Godwin, A.K., Emlet, D.R., Holgado-Madruga, M., Lanham, I.S., Joynes, C.J., Vo, A.J., Guha, A., and others. (2002) Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors. Am J. Pathol., 160, 441-447.
35. Ozaki, Y., Kontani, K., Hanaoka, J., Chano, T., Teramoto, K., Tezuka, N., Sawai, S., Fujino, S., Yoshiki, T., Okabe, H., and Ohkubo, I. (2002) Expression and immunogenicity of a tumor-associated antigen, 90K/Mac-2 binding protein, in lung carcinoma. Cancer, 95, 1954-1962.
36. Pajkos, G., Kiss, I., Sandor, J., Ember, I., and Kishazi, P. (2000) The prognostic value of the presence of mutations at the codons 12, 13, 61 of K-ras oncogene in colorectal cancer. Anticancer Res., 20, 1695-1701.
37. Rabinovich, G.A., Baum, L.G., Tinari, N., Paganelli, R., Natoli, C., Liu, F.T., and Iacobelli, S. (2002) Galectins and their ligands: amplifiers, silencers or turners of the inflammatory response? Trends Immunol., 23, 313-320.
38. Reed, J.C. (1999) Dysregulation of apoptosis in cancer. J. Clin. Oncol., 17, 2941-2953.
39. Riss, D., Jin, L., Qian, X., Bayliss, J., Scheithauer, B.W., Young, W.F. Jr., Vidal, S., Kovacs, K., Raz, A., and Lloyd, R.V. (2003) Differential expression of galectin-3 in pituitary tumors. Cancer Res., 63, 2251-2255.
40. Rosen, K., Rak, J., Leung, T., Dean, N.M., Kerbel, R.S., and Filmus, J. (2000) Activated Ras prevents downregulation of Bcl-X(L) triggered by detachment from the extracellular matrix. A mechanism of Ras-induced resistance to anoikis in intestinal epithelial cells. J. Cell Biol., 17, 447-456.
41. Rubistein, N., Alvarez, M., Zwirner, N.W., Toscano, M.A. Llaregui, J.M., Bravo, A., Mardoh, J., Fainboim, L., Podhajcer, O.L., and Rabinovich, G.A. (2004) Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection: a potential mechanism of tumor-immune privilege. Cancer Cell, 5, 241-250.
42. Sanjuan, X., Fernandez, P.L., Castells, A., Castronovo, V., van den Brule, F., Liu, F.T., Cardesa, A., and Campo, E. (1997) Differential expression of galectin 3 and galectin 1 in colorectal cancer progression. Gastroenterology, 113, 1906-1915.
43. Scambia, G., Panici, P.B., Baiocchi, G., Perrone, L., Iacobelli, S., and Mancuso, S. (1988) Measurement of a monoclonal-antibody-defined antigen (90K) in the sera of patients with ovarian cancer. Anticancer Res., 8, 761-764.
44. Schoppner, H.L., Raz, A., Ho, S.B., and Bresalier, R.S. (1995) Expression of an endogenus galactose-binding lectin correlates with neoplastic progression in the colon. Cancer, 75, 2818-2826.
45. Yamane, N., Tsujitani, S., Makino, M., Maeta, M., and Kaibara, N. (1999) Soluble CD44 variant 6 as a prognostic indicator in patients with colorectal cancer. Oncology, 56, 232-238.
46. Yang, R.Y., Hsu, D.K., and Liu, F.T. (1996) Expression of galectin-3 modulates T-cell growth and apoptosis. Proc. Natl Acad. Sci. USA, 93, 6737-6742.
47. Zauber, N.P., Sabbath-Solitare, M., Marotta, S.P., Zauber, A.G., and Bishop, D.T. (2001) Molecular changes in the Ki-ras and APC genes in colorectal adenomas and carcinomas arising in the same patient. J. Pathol., 193, 303-309.
48. Zhu, D., Keohavong, P., Finkelstein, S.D., Swalsky, P., Bakker, A., Weissfeld, J., Srivastava, S., and Whiteside, T.L. (1997) K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients. Cancer Res., 57, 2485-2489.